시장보고서
상품코드
1441199

세계의 신경 재활 기기 시장 규모, 점유율, 성장 분석, 제품별, 치료 영역별 - 산업 예측(2023-2030년)

Global Neurorehabilitation Devices Market Size, Share, Growth Analysis, By Product(Neurorobotics, Brain-computer interface), By Therapy Area(Stroke, Multiple Sclerosis) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 신경 재활 기기 시장 규모는 2022년 24억 9,000만 달러로 평가되었습니다. 2023년 28억 9,000만 달러에서 예측 기간(2024-2031년) 동안 15.9%의 연평균 복합 성장률(CAGR)로 2031년까지 94억 달러로 성장할 것으로 예상됩니다.

이 시장은 뇌졸중, 다발성 경화증, 파킨슨병, 뇌성마비 등 다양한 신경 질환에 대한 효과적인 재활 중재에 대한 수요 증가에 대응하기 위한 것입니다. 이 시장의 성장을 가속하는 주요 요인은 고령화 및 생활습관 변화와 같은 요인으로 인해 전 세계적으로 신경 질환의 유병률이 증가하고 있는 것입니다. 그 결과, 이러한 증상의 회복과 관리를 돕는 혁신적인 솔루션에 대한 수요가 증가하고 있습니다. 신경 재활 기기는 환자가 독립성을 회복하고 기능적 능력을 향상시키는 것을 목표로 하는 개인 맞춤형 치료를 제공합니다. 인공지능, 가상현실, 로봇공학 등의 기술 발전이 가져다주는 기회에도 불구하고, 신경재활기기 시장은 여러 도전과제에 직면해 있습니다. 여기에는 기기의 효과와 사용 편의성을 높이기 위한 지속적인 연구 개발의 필요성이 포함됩니다. 이러한 기술을 임상에 적용하기 위해서는 광범위한 조사, 임상시험 및 규제 당국의 승인이 필요합니다. 그럼에도 불구하고, 세계 신경 재활 기기 시장은 신경 질환을 앓고 있는 사람들의 재활 요구를 충족시키는 데 중요한 역할을 하고 있습니다. 유병률 증가와 같은 요인이 시장 성장을 가속하는 요인인 반면, 높은 비용과 제한적인 상환 정책 등의 문제도 존재합니다. 그러나 현재 진행 중인 연구 개발은 새로운 기술을 통합하고 신경 재활 서비스에 대한 접근성을 확대할 수 있는 기회를 제공합니다. 결국, 신경 재활 기기 시장은 환자의 삶을 개선하고 신경 재활 치료를 발전시키는 데 있어 큰 잠재력을 가지고 있습니다.

목차

주요 요약

  • 시장 개요
  • Wheel of Fortune

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별한 인사이트

세계의 신경 재활 기기 시장 : 제품별

  • 시장 개요
  • 뉴로보틱스
  • 뇌-컴퓨터 인터페이스
  • 웨어러블 디바이스
  • 비침습적 자극기

세계의 신경 재활 기기 시장 : 치료 영역별

  • 시장 개요
  • 뇌졸중
  • 다발성 경화증
  • 파킨슨병
  • 뇌성마비
  • 기타

세계의 신경 재활 기기 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Medtronic(US)
  • Abbott Laboratories(US)
  • Boston Scientific Corporation(US)
  • Stryker Corporation(US)
  • Smith & Nephew plc(UK)
  • Bioness Inc.(US)
  • Hocoma AG(Switzerland)
  • St. Jude Medical(US)
  • Ekso Bionics Holdings, Inc.(US)
  • Bioxtreme Robotics Rehabilitation(Italy)
  • ReWalk Robotics Ltd.(Israel)
  • Neurostyle Pte. Ltd.(Singapore)
  • Kinova Robotics(Canada)
  • Neuro Rehab VR(US)
  • Tyromotion GmbH(Austria)
  • Neofect(South Korea)
  • Enraf-Nonius(Netherlands)
  • Hobbs Rehabilitation(UK)
  • Motek Medical B.V.(Netherlands)
  • Biodex Medical Systems, Inc.(US)
LSH 24.03.21

Global Neurorehabilitation Devices Market size was valued at USD 2.49 Billion in 2022 and is poised to grow from USD 2.89 Billion in 2023 to USD 9.40 Billion by 2031, at a CAGR of 15.9% during the forecast period (2024-2031).

The market aims to meet the rising demand for effective rehabilitation interventions for diverse neurological conditions including stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy, among others. A key factor driving the growth of this market is the escalating prevalence of neurological disorders worldwide, attributed to factors like aging populations and lifestyle changes. Consequently, there is a significant need for innovative solutions aiding in the recovery and management of these conditions. Neurorehabilitation devices provide personalized therapies targeted at helping patients regain independence and enhance functional abilities. Despite opportunities presented by technological advancements like artificial intelligence, virtual reality, and robotics, the neurorehabilitation devices market encounters challenges. These include the necessity for continuous research and development to enhance device effectiveness and usability. Integrating such technologies into clinical practice requires extensive research, clinical trials, and regulatory approvals. Nevertheless, the global neurorehabilitation devices market plays a vital role in meeting the rehabilitation needs of individuals with neurological conditions. While factors such as increasing prevalence drive market growth, challenges such as high costs and limited reimbursement policies exist. Yet, ongoing research and development efforts present opportunities to integrate emerging technologies and broaden access to neurorehabilitation services. Ultimately, the neurorehabilitation devices market holds significant promise in improving patient lives and advancing neurorehabilitation therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurorehabilitation Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Neurorehabilitation Devices Market Segmental Analysis

The global neurorehabilitation devices market is segmented on the basis of product, therapy area, and region. In terms of product, the market is segmented into Neurorobotics, Brain-computer interface, Wearable devices, and Non-invasive Stimulators. By Therapy Area, the market is segmented into Refrigerant, Industrial Solvent, Silicone Polymers, Laboratory Chemicals, Chemical Intermediates, Methylating & Chlorinating Agent, Propellant & Blowing Agent, Catalyst Carrier, Herbicide, Local Anesthetic, Adhesives and Sealants, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurorehabilitation Devices Market

A key factor propelling the neurorehabilitation devices market is the ongoing progress in technology. Recent years have witnessed notable advancements in fields like robotics, virtual reality, wearable sensors, and brain-computer interfaces. These advancements have facilitated the creation of more refined and efficient neurorehabilitation devices, offering tailored therapies and individualized rehabilitation solutions for patients. For instance, robotic exoskeletons such as Ekso Bionics' EksoGT and ReWalk Robotics' ReWalk system are developed to aid individuals with mobility limitations in walking and enhancing their motor abilities.

The increasing occurrence of neurological conditions like stroke, multiple sclerosis, and Parkinson's disease is fuelling the need for neurorehabilitation devices. As per the World Health Organization, the global impact of neurological disorders is on the rise, primarily influenced by factors such as aging demographics and shifts in lifestyle patterns. Consequently, there's an escalating demand for efficient rehabilitation strategies aimed at assisting individuals in restoring functionality and enhancing their overall well-being.

Restraints in the Global Neurorehabilitation Devices Market

One of the main restraints in the neurorehabilitation devices market is the high cost associated with these devices. Advanced technologies, such as robotics and brain-computer interfaces, can make the devices expensive. Additionally, the specialized expertise required for their effective utilization can increase the overall cost of treatment. This cost factor can limit the accessibility of neurorehabilitation devices, particularly in regions with limited healthcare resources or inadequate insurance coverage.

Another challenge involves the restricted reimbursement policies concerning neurorehabilitation devices and therapies within certain healthcare systems. Reimbursement policies differ among countries, and in certain instances, the coverage for neurorehabilitation devices might be insufficient. This limited reimbursement scenario can present obstacles for both patients and healthcare providers, impeding the broad adoption of these devices and potentially restricting access to innovative neurorehabilitation treatments.

Market Trends of the Global Neurorehabilitation Devices Market

Tele-rehabilitation emerges as a prominent trend in the neurorehabilitation devices market, characterized by the uptake of remote rehabilitation solutions. Through tele-rehabilitation, patients can remotely access rehabilitation services via technology, connecting with healthcare professionals and participating in therapy sessions from the comfort of their homes. This trend has surged notably amid the COVID-19 pandemic, addressing constraints faced by in-person rehabilitation services. Tele-rehabilitation presents benefits such as convenience, enhanced accessibility, and opportunities for ongoing monitoring and personalized care

Customized and Dynamic Innovations: The neurorehabilitation market is experiencing a shift towards the creation of customized and adaptable technologies. These innovations strive to customize rehabilitation approaches based on the unique requirements, abilities, and progress of individual patients. Progress in sensor technology, artificial intelligence, and data analysis facilitates the gathering and assessment of patient-specific data, enabling the implementation of more precise and efficient rehabilitation regimens. Customized and adaptable technologies present the opportunity for improved results and increased patient involvement.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Neurorehabilitation Devices Market by Product

  • Market Overview
  • Neurorobotics
  • Brain-computer interface
  • Wearable devices
  • and Non-invasive Stimulators

Global Neurorehabilitation Devices Market by Therapy Area

  • Market Overview
  • Stroke
  • Multiple Sclerosis
  • Parkinson's Disease
  • Cerebral Palsy
  • and Others

Global Neurorehabilitation Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioness Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hocoma AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ekso Bionics Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioxtreme Robotics Rehabilitation (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ReWalk Robotics Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurostyle Pte. Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kinova Robotics (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuro Rehab VR (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tyromotion GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neofect (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enraf-Nonius (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hobbs Rehabilitation (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Motek Medical B.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biodex Medical Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제